Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: A multicenter, randomized, controlled trial

Anesthesia and Analgesia

Volumn 110, Issue 1, 2010, Pages 64-73

  Khuenl Brady, Karin S ^a   Wattwil, Magnus ^b   Vanacker, Bernard F ^c   Lora Tamayo, José I ^d   Rietbergen, Henk ^e   Álvarez Gómez, José A ^f  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e MERCK RESEARCH LABORATORIES   (United States)

^f Hospital Universitario   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPYRRONIUM BROMIDE; NEOSTIGMINE; OPIATE; SEVOFLURANE; SUGAMMADEX; VECURONIUM; CHOLINESTERASE INHIBITOR; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ARTICLE; BODY TEMPERATURE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTIVE SURGERY; ERYTHEMA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GEOMETRY; HEADACHE; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HOT FLUSH; HUMAN; HYPERTENSION; INTUBATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOGRAPHY; NAUSEA; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RETCHING; SIDE EFFECT; SLEEP DISORDER; SUPRAVENTRICULAR PREMATURE BEAT; VERTIGO; VOMITING; XEROSTOMIA; AGED; ANESTHETIC RECOVERY; COMPARATIVE STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROSTIMULATION; HEMODYNAMICS; MIDDLE AGED;

ADULT; AGED; ANESTHESIA RECOVERY PERIOD; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION; FEMALE; GAMMA-CYCLODEXTRINS; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 74049096781     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181ac53c3     Document Type: Article

References (26)

1. Pedersen T, Viby-Mogensen J, Ringsted C. Anaesthetic practice and postoperative pulmonary complications. Acta Anaesthesiol Scand 1992;36:812-818
2. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005;102:257-268
3. Berg H, Viby-Mogensen J, Roed J, Mortensen CR, Englbaek J, Skovgaard LT, Krintel JJ. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997;41:1095-1103
4. van Vlymen JM, Parlow JL. The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period. Anesth Analg 1997;84:148-154
5. Naguib M, Magboul MM, Samarkandi AH, Attia M. Adverse effects and drug interactions associated with local and regional anaesthesia. Drug Saf 1998;18:221-250
6. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993;3:335-348
7. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002;41:266-270
8. Bom A, Epemolu O, Hope F, Rutherford S, Thomson K. Selective relaxant binding agents for reversal of neuromuscular blockade. Curr Opin Pharmacol 2007;7:298-302
9. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006;96:36-43
10. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Østergaard D, Prins ME, Viby-Mogensen J. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex. A dose-finding and safety study. Anesthesiology 2006;104:667-674
11. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I. Effective reversal of moderate rocuronium or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106:283-288
12. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth Analg 2007;104:563-568
13. de Boer HD, Staals LM, Driessen JJ, van de Pol F, Bom A, van Egmond J. The effect of sugammadex (Org 25969) on profound neuromuscular block as induced by vecuronium in the anaesthetized Rhesus monkey. Eur J Anaesthesiol 2006;23(suppl 37): 138 (Abstract A-533)
14. Hope F, Bom A. Rapid reversal of vecuronium induced block with sugammadex in three species. Eur J Anaesthesiol 2006; 23(suppl 37):139 (Abstract A-535)
15. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007;51:789-808
16. Viby-Mogensen J, Englbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS, Koscielniak-Nielsen Z, Skovgaard LT, Østergaard D. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996;40:59-74
17. Bland JM, Altman DG. Transforming data. BMJ 1996;312:770
18. Bland JM, Altman DG. The use of transformation when comparing two means. BMJ 1996;312:1153
19. Bland JM, Altman DG. Transformations, means, and confidence intervals. BMJ 1996;312:1079
20. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003;98:1037-1039
21. Fuchs-Buder T, Mencke T. Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting). Eur J Anaesthesiol 2001;18(suppl 23):53-59
22. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003;98:1042-1048
23. Pü hringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different timepoints: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008;109:188-197
24. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998;87:936-940
25. Reid JE, Breslin DS, Mirakhur RK, Hayes AH. Neostigmine antagonism of rocuronium block during anesthesia with sevoflurane, isoflurane or propofol. Can J Anaesth 2001;48:351-355
26. Booij LHDJ, de Boer HD, van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: reasons for and development of a new concept. Semin Anesth Periop Med Pain 2002;21:92-98